Back
Recursion Pharmaceuticals, Inc. Stock Predictions
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
33
RXRX
Recursion Pharmaceuticals, Inc.
Last Price:
$4.66
Seasonality Move:
-31.27%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atRecursion Pharmaceuticals, Inc. Stock Forecast
-
Is Recursion Pharmaceuticals, Inc. Stock Undervalued?The current Recursion Pharmaceuticals, Inc. [RXRX] share price is $4.67. The Score for RXRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
RXRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Recursion Pharmaceuticals, Inc. Stock Go Up Next Year?
Data Unavailable
Recursion Pharmaceuticals, Inc. Stock Rating
Data Unavailable
Recursion Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
recursion.com
52-Week Data
52-Week High:
12.36
52-Week Low:
3.79
Prediction Charts
Market Cap:
2.4B
Price in USD:
4.67
Volume:
21.4M
Beta:
0.95
Technical Analysis
SMA50:
4.48
SMA100:
4.88
SMA200:
5.02
52-Wk Change:
-27.03%
Stock Predictions
-
Is Recursion Pharmaceuticals, Inc. stock public?Yes, Recursion Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Recursion Pharmaceuticals, Inc. stock quote today?The Recursion Pharmaceuticals, Inc. stock price is 4.67 USD today.
-
How to buy Recursion Pharmaceuticals, Inc. stock online?You can buy Recursion Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-26 | 4.41 | 4.25 | 4.41 | 4.23 |
| Dec-29 | 4.18 | 4.13 | 4.31 | 4.11 |
| Dec-30 | 4.15 | 4.11 | 4.21 | 4.10 |
| Dec-31 | 4.10 | 4.09 | 4.14 | 4.05 |
| Jan-5 | 4.26 | 4.37 | 4.42 | 4.25 |
| Jan-6 | 4.36 | 4.55 | 4.66 | 4.35 |
| Jan-7 | 4.56 | 4.86 | 5.00 | 4.54 |
| Jan-8 | 4.80 | 4.70 | 4.80 | 4.65 |
| Jan-9 | 4.78 | 4.66 | 4.82 | 4.62 |
| Jan-12 | 4.76 | 4.81 | 4.98 | 4.72 |
| Jan-13 | 4.88 | 4.69 | 4.96 | 4.63 |
| Jan-14 | 4.62 | 4.85 | 4.87 | 4.61 |
| Jan-15 | 4.85 | 4.64 | 4.87 | 4.63 |
| Jan-16 | 4.65 | 4.67 | 4.88 | 4.55 |
Recursion Pharmaceuticals, Inc. Earnings
Data Unavailable
Recursion Pharmaceuticals, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.23 per share.
* Recursion Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.